Global Cell Cryopreservation Equipment Market 2026 – 2035

Reports Description

As per the Cell Cryopreservation Equipment Market analysis conducted by the CMI team, the cell cryopreservation equipment market is expected to record a CAGR of 12.34% from 2026 to 2035. In 2026, the market size was USD 3.09 Billion. By 2035, the valuation is anticipated to reach USD 8.73 Billion.

Overview

The cell cryopreservation equipment industry is witnessing the launching of smart IoT monitoring, automated freezers, and ultra-low-temperature storage. New cryoprotectants equipped with advanced systems enhance cell reproducibility, viability, and scalability for commercial and clinical therapies. Along these lines, CPC, in September 2024, introduced the MicroCNX ULT aseptic micro-connector for CGT freeze cassettes, thereby strengthening the cryogenic workflows and catalyzing the cell cryopreservation equipment market.

The cell cryopreservation equipment market is seeing businesses combining innovative solutions with cutting-edge cryopreservation technologies in order to meet the rising demand for high-performance, scalable therapeutic cell storage.

Market Highlights

• North America held 47.34% of the market share in 2025.

• The Asia Pacific is expected to witness the fastest CAGR of 12.78% during the forecast period.

• The consumables/accessories segment dominated in 2025 with 62.34% of the market share.

• The equipment segment is expected to witness the fastest CAGR of 13.54% during the forecast period.

• The stem cell segment dominated the market in 2025 with 49.35% of the market share.

• The immune cell segment is expected to witness the fastest CAGR of 10.47% during the forecast period.

• The biopharmaceutical & pharmaceutical companies segment held the largest market share of 43.64% in 2025.

• The biobanks segment is expected to witness the fastest CAGR of 10.75% during the forecast period.

Key Trends & Drivers

• Advancements in Cellular Therapies and Increased Frequency of Biobanking Activities

Advancements in CAR-T cell therapies are amplifying the demand for cryopreservation of cells. The cellular therapies imply infusion as well as manipulation of donor-derived/patient-specific cells. Precise precision methods are needed for maintaining the therapeutic efficacy of these therapies.

Biological samples are stored to serve clinical and research purposes, which do necessitate efficient cell cryopreservation methods for maintaining functionality and viability of different cell types over the extended periods. The biobanks do act as repositories for various cellular materials that include tissues and stem cells, thereby driving the requirement of strong cryopreservation solutions for ascertaining stored specimens’ long-term integrity.

What's trending in the Cell Cryopreservation Equipment Market?

Automated cryopreservation systems integrated with IoT for remote monitoring, real-time tracking, and accurate temperature control are turning out to be the norm. Rising demand for preservation of sensitive cells such as iPSCs for personalized diagnostics and cell therapies is bound to keep the cash registers ringing for the cell cryopreservation equipment market during the forecast period. Developing safer antifreeze compounds for preventing cell damage during thawing/freezing is on the anvil. AI is also being used for predictive analytics for monitoring sample integrity and preventing temperature excursions.

Key Threats

Concerns regarding cell damage do pose a visible threat to the cell cryopreservation equipment market. Cryoprotectants are likely to cause extra stress on the cells. Assuring of minimal damage during cryopreservation is amongst the complex challenges, especially for the delicate types of cells that are vital in biomedical applications. Also, standardization of cryopreservation procedures across diverse cell lines as well as applications is difficult owing to different needs of different cells. This factor tends to hamper uniform practices, thereby limiting the ease of implementation and accessibility for organizations and researchers looking to leverage cryopreservation.

Opportunities

Continuous research & development activities in freezing methodologies and cryoprotectant formulations are replenishing the cell cryopreservation equipment market, thereby ascertaining improved cell functionality and viability post-thawing. Innovations in cryoprotectants in the form of enhanced properties, like increased permeability and reduced toxicity, do contribute toward minimization of cellular damage during the thawing and freezing process. These advancements also reflect the alignment with rising demand for precision medicine. The ability to preserve cells with higher efficiency helps in the expansion of the scope of cryopreservation across several biomedical disciplines.

Category Wise Insights

By Product

• Equipment

The equipment segment is expected to witness the fastest CAGR in the cell cryopreservation equipment market during the forecast period. This is credited to the increased investments in advanced technologies, rising demand for high-performance machinery, rising automation, and expansion of industrial applications across developed as well as emerging markets.

• Consumables/Accessories

The consumables/accessories segment led the cell cryopreservation equipment market in 2025 and the scenario is expected to persist during the forecast period. This is owing to the rising demand for reliable, high class products, rising adoption across various end-use verticals, increased frequency of replacement cycles; and growing awareness regarding product efficiency, thereby improving performance and durability.

By Application

• Stem Cells

The stem cells segment dominated the cell cryopreservation equipment market in 2025 and the status quo is expected to remain unchanged during the forecast period. This is due to rising clinical and research applications, increased adoption through regenerative medicine, growing awareness of therapeutic potential, and supportive initiatives by the governments for advanced cell-based therapies.

• Reproductive Cells

The reproductive cells segment is expected to witness the fastest CAGR in the cell cryopreservation equipment market during the forecast period. This is basically driven by rising demand for fertility treatments, advancements in the assisted reproductive technologies, growing awareness of reproductive health, and increased investments in clinical and research applications.

• Bioproduction Cell Lines

Immune cells (like Tregs), stem cells, and the other engineered cells are important for personalized treatments and regenerative medicine. They need cryopreservation for storage, right from harvest to the therapeutic use. Cryopreservation does prevent genetic drift and microbial contamination, thereby maintaining the cell banks for consistent production of drugs (such as antibodies). Demand for therapeutic proteins (from CHO) is also responsible for the growth of the cryopreservation equipment market.

• Primary Cells

Primary cells are driving the cell cryopreservation equipment market by fueling the demand for advanced storage solutions. Primary cells (such as immune cells and stem cells) are the epicenter of treatments for various diseases. Cryopreservation does keep them viable till they are needed, thereby creating higher demand for LN₂ storage, freezers, and monitoring systems. The cells of patients are cryopreserved for various targeted treatments, wherein strong infrastructure is needed for individual patient requirements, thereby raising sales of equipment.

By End-use

• Biopharmaceutical & Pharmaceutical Companies

The biopharmaceutical & pharmaceutical companies dominated the cell cryopreservation equipment market in 2025 and the situation is expected to remain the same during the forecast period. This is due to increased R&D spending, expansion of the production pipeline, increased usage of advanced therapies, growing focus on personalized medicine, and strategic partnerships for expanding the market reach.

• Academic and Research Institutes

Research institutes do establish huge biobanks in order to store diverse cell lines, samples, and tissues, thereby creating a continuous demand for long-term, reliable cryopreservation equipment along with expansion of biorepositories. Academic institutes necessitate high-quality, automated systems for long-term storage and reliable innovation via investments in R&D activities.

• Biobanks

The biobanks segment is expected to witness the fastest CAGR in the cell cryopreservation equipment market during the forecast period. This is attributed to rising demand for stored biological samples in clinical and research trials, increased investments in personalized medicine and genomics, technological advancements in sample preservation, and increased collaborations between pharmaceutical companies and research institutions.

• IVF Clinics

IVF clinics held a significant market share in 2025 and would continue with a similar streak during the forecast period. This is due to the fact that IVF clinics use cryopreservation for storing embryos, sperm, and eggs for assisted reproductive technologies. One of the notable trends implies growing adoption of vitrification (a freezing technique) for enhanced rates of survival during thawing.

Historical Context

The increased adoption of regenerative medicine, cell-based treatments, and stem cell therapy is amongst the major drivers of the cell cryopreservation equipment market. As therapeutic cells are needed to stay genetically stable and viable all through extraction, processing, transportation, and clinical administration, cryopreservation is necessary for storage in the long run without compromising cell integrity. With the pipeline of cellular therapeutics expanding, cryopreservation has turned out to be an important step in quality control, therapy development, and delivery.

Increased numbers of clinical trials regarding cell therapies at the commercial level are compelling the research institutions, pharmaceutical companies, CDMOs, and biobanks to upscale their cryopreservation capability. Ultra-low-temperature systems, controlled-rate freezers, liquid nitrogen-based platforms, and smart inventory solutions are, as such, central to the distribution of advanced cell therapies and industrial bioprocessing.

How is AI shaping the Cell Cryopreservation Equipment Market?

AI is used in the research phase for modelling the molecular interactions, which, in turn, does accelerate the development of less toxic, new cryoprotectants with more efficient preservation solutions. AI-enabled data management systems help in improving traceability of samples, inventory management, and cataloguing, which are important for adhering to strict regulatory standards such as the ones from the U.S. FDA for good manufacturing practices (GMP) and clinical applications. Also, AI-enabled predictive analytics aids the laboratories in forecasting the need for maintenance of equipment much before the occurrence of failures, which does reduce operational costs, downtime, and risk pertaining to catastrophic sample loss.

How are the U.S. Tariffs affecting Cell Cryopreservation Equipment Market?

Tariffs are raising prices on the imported components such as nucleic acids, LCDs, and plastics from China, thereby tweaking the margins for U.S.-based research labs and biotech firms. The market players are thus looking out for alternatives in the form of shifting the production or sourcing from economies such as Ireland, South Korea, and Mexico for avoiding duties. This trend is called friend-shoring or nearshoring. Also, higher costs of procurement for equipment such as freezers mean a rise in the operational expenses for labs and clinics, whereby they are straining research budgets and slowing down the incorporation of advanced therapies.

Report Scope

Regional Perspective

The cell cryopreservation equipment market is classified into North America, Europe, Asia Pacific, and LAMEA.

• North America

North America dominated the cell cryopreservation equipment market in 2025. This is credited to a robust emphasis on technological innovation coupled with extensive research conducted pertaining to cryopreservation methods. The U.S. is also home to a well-established biomedical research sector along with growing adoption of personalized medicine. The preservation of cells allows for the development of innovative products in the healthcare vertical owing to the growing incidences of diseases herein.

• Asia Pacific

The Asia Pacific is expected to witness the fastest CAGR in the cell cryopreservation equipment market during the forecast period. This can be credited to the expansion of healthcare and bioapplication sectors, the growing adoption of cell-based therapies, the expansion of research infrastructure, and increased investments in fertility preservation and biobanking services across Japan, India, and China. In July 2025, EPIA did launch India’s first Pan-India at-home egg freezing program.

• Europe

Europe is expected to grow on a substantial note in the cell cryopreservation equipment market during the forecast period owing to higher adoption of cell-based therapies and regenerative medicine, advanced healthcare infrastructure, well-established biobanks, and robust support from the governments for R&D activities. The UK’s cell cryopreservation equipment market is driven by visible advancements in healthcare. Germany’ market is growing due to the presence of a strong biopharmaceutical sector herein.

• LAMEA

Brazil and Argentina in LATAM and Kuwait, Iran, and South Africa in MEA are leading the cell cryopreservation equipment market. In May 2025, Iranian knowledge-based companies had localized the embryo cryopreservation equipment for use in IVF nationwide, thereby sharply reducing the reliance on imports.

Key Developments

The cell cryopreservation equipment market is witnessing a notable organic and inorganic expansion. Some of the key developments include -

• In May 2025, Azenta Life Sciences introduced the sub-150 degree C Cryo Carrier in the U.K., thereby offering a trackable, portable, LN₂ vapor-based solution for safer lab-to-lab transportation of biological materials that are temperature-sensitive.

• In April 2025, BioLife Solutions completed the acquisition of PanTHERA CryoSolutions (Canada) for integrating its IRI cryopreservation technology, thereby strengthening the former’s CGT biopreservation portfolio and extending support to the demand for advanced equipment for cryopreservation.

• In March 2025, MVE Biological Solutions from Cryoport did launch the High-Efficiency 800 degree C cryogenic freezer in the U.S., thereby expanding the HE Series in meeting workflow needs and capacity of biorepositories, fertility clinics, and clinical laboratories.

Leading Players

The cell cryopreservation equipment market is highly niche. Some of the key players in the market include:

• Thermo Fisher Scientific Inc.
• Azenta US Inc.
• MVE Biological Solutions
• INOXCVA
• Haier Biomedical
• Kirsch GmbH
• Planer (a Hamilton Thorne company)
• Eppendorf SE
• Labtron Equipment Ltd.
• Others

These firms apply numerous strategies to enter the market, including innovations, mergers and acquisitions, and collaboration. The cell cryopreservation equipment market is shaped by the presence of diversified players that compete based on product innovation, vertical integration, and cost efficiency.

Regional Coverage:

North America

• U.S.
• Canada
• Mexico
• Rest of North America

Europe

• Germany
• France
• U.K.
• Russia
• Italy
• Spain
• Netherlands
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• New Zealand
• Australia
• South Korea
• Taiwan
• Rest of Asia Pacific

The Middle East & Africa

• Saudi Arabia
• UAE
• Egypt
• Kuwait
• South Africa
• Rest of the Middle East & Africa

Latin America

• Brazil
• Argentina
• Rest of Latin America